Clinical diagnostics have made a significant leap since the advent of genetic testing. Notably, genetic diagnostics is also playing a critical role today in identifying and mitigating the COVID-19 pandemic.
Meanwhile, today, as researchers are discovering more biomarkers, it is aiding in understanding many complex disorders, including a variety of cancers. In that regard, one specific genetic diagnostics technique that has gained a lot of attention lately is clustered regularly interspaced short palindromic repeat (CRISPR).
Thanks to CRISPR’s remarkable gene editing and cleaving abilities, it is extensively being leveraged in a variety of applications related to genome editing and genetic engineering. CRISPR is also used in many diagnostic applications today to diagnose several infectious and non-infectious diseases. There is also an increasing demand for polymerase chain reaction (PCR), next-generation sequencing (NGS), and serology-based diagnostic techniques.
Leading-edge technologies, such as artificial intelligence (AI) and blockchain, are also playing an important role in revolutionizing
the diagnostic processes. While AI is enabling the rapid testing of millions of RNA and DNA strands in the shortest time possible, blockchain technology is leveraged to secure these vast amounts of data and share it among key stakeholders.
At this juncture, there is a variety of genetic diagnostics solution providers and service companies available in the market that cater to the different needs of healthcare organizations. To help them choose the solution provider or service company that best fits their requirement, Healthcare Tech Outlook has compiled
lists of the top 10 genetic diagnostics solution providers and top 10 genetic diagnostics service companies. Besides, the magazine also comprises insights from thought leaders in the sector on the industry trends, best practices, recent innovations, and their advice for aspiring CIOs.
We present to you Healthcare Tech Outlook’s, and “Top 10 Genetic Diagnostics Service Companies -2021.”